Stay updated with breaking news from Forefront Analytics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Nkarta, Inc. (NASDAQ:NKTX – Free Report) – Stock analysts at William Blair reduced their Q2 2024 earnings per share (EPS) estimates for shares of Nkarta in a report issued on Tuesday, June 27th. William Blair analyst S. Corwin now forecasts that the company will post earnings per share of ($0.80) for the quarter, down from […]
CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Rating) has been assigned an average recommendation of “Hold” from the twelve ratings firms that are covering the stock, Marketbeat Ratings reports. One investment analyst has rated the stock with a sell recommendation, eight have assigned a hold recommendation and three have given a buy recommendation to the company. […]
Pathstone Family Office LLC increased its holdings in shares of iShares Gold Trust (NYSEARCA:IAU – Get Rating) by 12.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 121,231 shares of the exchange traded fund’s stock after buying an additional […]
Tang Capital Management LLC acquired a new stake in Athira Pharma, Inc. (NASDAQ:ATHA – Get Rating) in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 485,234 shares of the company’s stock, valued at approximately $1,538,000. A number of other institutional investors also recently bought and […]
Forefront Analytics LLC decreased its position in shares of CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Rating) by 48.2% in the 4th quarter, HoldingsChannel reports. The fund owned 24,787 shares of the biotechnology company’s stock after selling 23,082 shares during the period. Forefront Analytics LLC’s holdings in CytomX Therapeutics were worth $40,000 as of its most […]